Delivery Order SPE2DB20D1100-SPE2DB25FD9L8
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,271.97 to AmerisourceBergen Drug Corp for the supply of Sumatriptan 6 mg/0.5 mL auto-injectors. This competitive award, issued on August 4, 2025, with an ultimate completion date of August 5, 2025, represents a firm fixed price delivery order with no set-aside designation. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and...
- The Defense Logistics Agency awarded a delivery order valued at $3,137.07 to AmerisourceBergen Drug Corp for the supply of Sumatriptan 6 mg/0.5 mL auto-injectors. The contract, awarded on July 23, 2025, with a completion date of July 24, 2025, utilizes firm fixed pricing with no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,249.60 to AmerisourceBergen Drug Corp for the supply of Sumatriptan 6 mg/0.5 mL auto-injector units. This competitive award, issued on July 18, 2025, with an ultimate completion date of July 21, 2025, represents a firm fixed-price contract with no set-aside designation. The product will be delivered to a location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency awarded a $2,412.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Sumatriptan 6 mg/0.5 mL auto-injectors. The contract, with an ultimate completion date of July 25, 2025, was awarded on July 24, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a small-value transaction within...
- The Defense Logistics Agency awarded a delivery order valued at $4,413.01 to AmerisourceBergen Drug Corp for Sumatriptan 6 mg/0.5 mL auto-injector units. This firm fixed-price contract, awarded on August 25, 2025, with an ultimate completion date of August 26, 2025, represents a routine pharmaceutical supply transaction under the company's broader federal contracting relationship with DLA. The award was made through open competition with no set-aside designation and will be fulfilled from...
- The Defense Logistics Agency awarded a $2,422.85 delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Sumatriptan 6 mg/0.5 mL auto-injectors. This firm fixed-price contract, with an ultimate completion date of August 1, 2025, represents a non-set-aside competitive award executed through the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Sumatriptan 6 mg/0.5ml auto-injectors with a ceiling value of $12,080.19. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of September 9, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role as a critical...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Sumatriptan 6 mg/0.5 mL auto-injectors valued at $2,652.22. This competitively awarded, firm fixed-price delivery order will be fulfilled from the contractor's Conshohocken, Pennsylvania facility, with an ultimate completion date of August 8, 2025. The award represents a routine pharmaceutical supply transaction under a non-set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $2,914.29 to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Sumatriptan 6 mg/0.5 mL auto-injectors. This competitive, firm fixed-price delivery order is scheduled for completion by August 6, 2025, with performance occurring at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation and represents a single procurement action under the company's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Sumatriptan 6 mg/0.5 mL auto-injector units valued at $1,129.39, with an ultimate completion date of August 20, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and is classified as a child contract, indicating it derives from a larger indefinite delivery contract (IDC) vehicle. The pharmaceutical product will be performed and delivered from AmerisourceBergen's...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD9L8Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,981.55 to AmerisourceBergen Drug Corp for the supply of Sumatriptan 6 mg/0.5 mL auto-injector units. This is a firm fixed price delivery order with an ultimate completion date of August 11, 2025, issued on August 8, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. No set-aside designation was applied to this award, indicating it was competitively awarded through open competition. This delivery order is issued under a larger Indefinite Delivery Contract vehicle, the DLA Troop Support Medical SPE2DX Pharmaceutical Prime Vendor Global Program, valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency. The company maintains an extensive portfolio of federal contract awards encompassing a comprehensive range of pharmaceutical products and medical supplies across multiple therapeutic domains. As a child contract under the parent SPE2DX indefinite delivery vehicle, this Sumatriptan delivery order exemplifies AmerisourceBergen's role as a primary supplier of specialty medications and medical commodities to Defense Health Agency customers and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.0k | 8/8/25 |